Top 10 Components

DBA: GoPuff, Inc., the company provides a delivery service for daily essentials including food, alcohol, pet supplies, and more. Current Valuation: $6.2 B
Workato provides integration platform powered by Intelligent Automation. The platform enables both business and IT to integrate their apps and automate workflows without compromising security and governance. Current Valuation: $6.0 B
Benchling is a life sciences software company that provides a cloud-based platform for biotech research and development, enabling scientists to design, share, and manage DNA sequences and experiments in a collaborative environment. Current Valuation: $5.9 B
Gusto is a cloud-based platform that provides payroll, benefits, and human resource management services to small and medium-sized businesses, helping them streamline administrative tasks and comply with regulations. Current Valuation: $5.9 B
Nuro is an autonomous vehicle technology company that specializes in developing self-driving electric delivery vehicles designed to transport goods and groceries, aiming to improve safety and efficiency in last-mile delivery services. Current Valuation: $9.3 B
Sierra Space specializes in the development and manufacturing of advanced space systems, including spacecraft, satellites, and space habitats, for commercial, scientific, and governmental missions. Current Valuation: $5.4 B
Cerebras Systems Inc. is an American artificial intelligence company with offices in Sunnyvale, San Diego, Toronto, and Bangalore, India. Cerebras builds computer systems for complex AI deep learning applications.
dbt Labs empowers data teams to build reliable, governed data pipelines—accelerating analytics and AI initiatives with speed and confidence.
Lyra Health is a digital mental health company that provides an online platform connecting employees with personalized, evidence-based mental health care services to improve their well-being and productivity. Current Valuation: $5.1 B
Reify Health is paving the way to faster, predictable, and more accessible clinical trials. Current Valuation: $5.0 B